EU Novel Food Approval Expands Market for Bone Health Benefits
Mar 29, 2012 – DuPont Nutrition & Health is poised to bring a new health opportunity to the European food industry with this week’s EU approval of a new proprietary vitamin K2 product as a novel food.
Part of the DuPont™ Danisco® range of ingredients, this product is a new unique commercial form of vitamin K2, entering the range as ActivK™ S, our pure Vitamin K2 made by organic synthesis.
Approved Health Claim
Food products and dietary supplements containing the vitamin qualify for an EU-approved bone health claim. Benefits for cardiovascular health are also well-documented.
Thanks to the novel food approval, DuPont can now expand its ActivK™ portfolio in Europe with an additional high-value product.
“EU approval of this new, unique form of vitamin K2 creates tremendous opportunities for food and dietary supplement manufacturers to take vitamin K2 into mainstream application due to a better cost-in-use proposition.
It opens up new horizons to enhance the health profile of their products and brands, and an important differentiator for our customers also is our scientific, regulatory and global application expertise on vitamin K2,” said Didier Carcano, vice president of health platforms at DuPont Nutrition & Health.
DuPont has developed a number of inspirational concepts that demonstrate the use of ActivK™, which is already sold in Europe in its natural form. Stable under most processing conditions, the ActivK™ K2 vitamins are suitable for dairy and bakery products, beverages, cereals, fats and oils, nutritional bars, infant formula and dietary supplements.
This new unique form of vitamin K2 has been developed by Kappa Bioscience in Norway. In 2011 DuPont entered an agreement with Kappa to cooperate on expanding sales to global markets, and the new vitamin was launched in selected markets already last year.
Vitamin K is a group of fat-soluble vitamins known to be critical in blood coagulation. Vitamin K is divided into K1 (clotting activity) and K2, which also has extra hepatic activities. Vitamin K2 as menaquinon-7 (MK-7) has the highest bioavailability and proven effects on bone health (EFSA 13.1 Claim) and cardiovascular health. Vitamin K2 acts as co-factor for proteins involved in calcium metabolism.
Mar 29, 2012
DuPont™ Danisco® is the brand for a range of products that help provide enhanced bioprotection, an improved nutritional profile, and better taste and texture with greater cost efficiency and lower environmental impact, meeting the needs of manufacturers of food and beverages, dietary supplements and pet food. Through the work of the global network of food scientists and technologists in DuPont, the Danisco® range is supported by a uniquely broad spectrum of know-how across applications and processing. www.danisco.com
DuPont Nutrition & Health addresses the world’s challenges in food by offering a wide range of sustainable, bio-based ingredients and advanced microbial diagnostic solutions to provide safer, healthier and more nutritious food. Through close collaboration with customers, DuPont combines knowledge and experience with a passion for innovation to deliver unparalleled customer value to the marketplace.
DuPont (NYSE: DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials, and services since 1802. The company believes that by collaborating with customers, governments, NGOs, and thought leaders we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment. For additional information about DuPont and its commitment to inclusive innovation, please visit www.dupont.com.
The DuPont Oval Logo, DuPont™, The miracles of science™, Danisco® and ActivK™ are registered trademarks or trademarks of DuPont or its affiliates.